LONDON – Evotec AG is lining up a three-armed deal with Sanofi SA, which will see it taking on responsibility for five preclinical oncology programs, assuming operational control of a 200-strong drug discovery facility and acting as chief scout for academic research projects on behalf of the French pharma company.